Savara Inc. Faced Class Action Lawsuit Over Securities Purchases

Rosen Law Firm has filed a class action lawsuit against Savara Inc. (NASDAQ: SVRA) on behalf of investors who purchased securities between March 7, 2024 and May 23, 2025. The lawsuit alleges that Savara made false or misleading statements during this period. If you purchased Savara securities during the Class Period, you may be entitled to compensation without payment of any out of pocket fees or costs. To join the class action, visit https://rosenlegal.com/submit-form/?case_id=44874 or call Phillip Kim, Esq. at 866-767-3653.

Rosen Law Firm has filed a class action lawsuit against Savara Inc. (NASDAQ: SVRA) on behalf of investors who purchased securities between March 7, 2024 and May 23, 2025. The lawsuit alleges that Savara made false or misleading statements during this period, which led to significant losses for investors.

The lawsuit, filed by Rosen Law Firm, claims that Savara made materially false and misleading statements and/or failed to disclose critical information about its business, operations, and prospects. Specifically, the complaint alleges that Savara failed to disclose that:

1. The MOLBREEVI Biologics License Application (BLA) lacked sufficient information regarding MOLBREEVI's chemistry, manufacturing, and/or controls.
2. The FDA was unlikely to approve the MOLBREEVI BLA in its current form.
3. This made it unlikely that Savara would complete its submission of the MOLBREEVI BLA within the timeframe it had represented to investors.
4. The delay in MOLBREEVI's regulatory approval increased the likelihood that Savara would need to raise additional capital.
5. As a result, Savara's public statements were materially false and misleading at all relevant times.

The lawsuit seeks to recover damages on behalf of all persons and entities that purchased or otherwise acquired Savara securities during the Class Period. Investors who purchased Savara securities during this time may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.

To join the class action, investors can visit [Rosen Legal's website](https://rosenlegal.com/submit-form/?case_id=44874) or call Phillip Kim, Esq. toll-free at 866-767-3653. The deadline to request appointment as lead plaintiff is November 7, 2025.